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Background: The association between epilepsy and depressive illness has long been established. However, though various
explanations—psychosocial and anatomical—have been proposed findings from studies are inconsistent and often contradictory.
Aims: This study aimed to compare the features of those people with epilepsy seen in a secondary care setting who developed a
depressive illness with those that did not.
Method: Information regarding the patient’s epilepsy, history and presence of depressive illness and perceived social functioning
was gathered from case notes, questionnaire and patient interview.
Results: The experience of a depressive episode was associated with the presence of a right-sided lesion, attacks occurring
more than once each month, diagnosis made in adulthood and a perceived marked effect of the epilepsy on mobility and social
activity.
Conclusion: These findings are not all consistent with work already carried out in this field. However, they do point to a
multifactorial aetiology of depressive illness in this group as is the case in the general population. Possible explanations for
frequently contradictory findings are discussed.
c© 2002 Published by Elsevier Science Ltd on behalf of BEA Trading Ltd.
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INTRODUCTION
An association between epilepsy and depressive
illness has long been recognized (at least since
Hippocrates1) though establishing the mechanism
behind this has proved more elusive. Dysphoric
symptoms are common peri-ictally and are usually
considered to share an aetiology with the epileptic
attacks. The cause of an increased incidence of
interictal depressive illness, is however, thought to be
multifactorial and more varied. Links with laterality of
focus have not been consistent between studies though
there does seem to be a more specific association
with temporal lobe epilepsy2 and a greater weight
of evidence to suggest a left-sided association3–5.
Psychosocial factors are frequently put forward to
explain this increased prevalence with Hermann6
describing it as analogous to the learned helplessness
theory of depression by Seligman7, though the evident
excess in prevalence when compared with other
equally disabling conditions3 would suggest this is
not a complete explanation. To add to the already
complex association between epilepsy and mood, it
has been well documented that certain anti-epileptic
drugs (e.g. carbamazepine, vigabatrin and topiramate)
have direct effects on the patient’s mood as well
as some potentially distressing side-effects. It seems
most likely that, as with the population as a whole,
there are several factors that determine the likelihood
of an individual developing a depressive illness.
One complicating factor in many of the studies to
date is that the subjects have been drawn from tertiary
referral centres and thus, can not be said to be repre-
sentative of people with epilepsy as a whole. The pop-
ulation in this study were seen as a secondary service
(under the care of P. C.) and, as well as a full clinical
examination, were investigated with electroencephalo-
gram (EEG) and either computerized tomography (CT
scan) or nuclear magnetic resonance imaging (MRI) to
establish any epileptic focus. Along with a question-
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naire about the effect of epilepsy on various aspects
of the patient’s life, this was intended to establish the
effect of anatomical and psychosocial factors on the
genesis of depressive illness in those with epilepsy.
METHOD
Sample selection
All people attending at a specialist outpatient clinic
during a 6 month period were initially identified.
Patients were excluded from the study for the
following reasons: age under 16 or over 65 years, not
agreeing to take part in the study, no definite diagnosis
of epilepsy made, incomplete questionnaires returned,
referred from another secondary service or diagnosis
of learning disability previously made.
Information collected
Information was gathered from questionnaires com-
pleted by the patient sample, from study of the case
notes and, in some cases by examination by a psychia-
trist. The patient questionnaires comprised the follow-
ing: a series of Likert scales to identify the patient’s
subjective impression of the effect of epilepsy on their
life (covering work, relationships, side effects of medi-
cation, mobility and socializing), secondly a question-
naire to establish the patient’s perception of frequency
of attacks and past diagnosis or treatment of depressive
illness, and, finally, a hospital anxiety and depression
scale (HAD)8 for completion. If the HAD suggested
that the patient may have a depressive illness, then
they were offered an appointment with a psychiatrist
(G. B.) in order to establish whether this was truly the
case and if necessary offer appropriate treatment.
The information gathered from the case notes
included whether the patient had been diagnosed with,
or treated for, a depressive illness in the past, the type
of epilepsy diagnosed, when this diagnosis was first
made, current anti-epileptic medication, reported fit
frequency and the results of investigations to localize
a lesion.
Definition of depressive illness
Patients were identified by whether they were or
had whilst having epilepsy, experienced a depressive
illness. A depressive illness was taken to have been
present in the past if there was evidence in the case
notes that it had been diagnosed by a psychiatrist or
general practitioner. A current episode was taken as
been present if, in accordance with ICD 10, a diagnosis
of moderate or severe depressive illness was made by
the psychiatrist (G. B.) (usually following completion
of the HAD). The cut-off point for further assessment
after the HAD scale was taken as a score of 8. Patients
scoring 8 or more but declining interview by the
psychiatrist were excluded from the study as it has
been shown that whilst it is a sensitive instrument, the
HAD scale has poor positive predictive value9.
RESULTS
In all, 130 patients attending the epilepsy clinic
fulfilled the criteria for inclusion in the study. Of
these, 78 (60%) agreed to take part in the study
and fully completed the three questionnaires. Thirteen
agreed to take part but failed to fully complete
the questionnaires and thus were excluded form the
study. Fifteen (19%) of the full responders had a
history of depressive illness as described above and
16 (21%) had a current episode identified by HAD
scale and clinical interview. A further four patients
who scored over 8 on the HAD scale had to be
excluded from the study as they declined an interview
with the psychiatrist which would have confirmed
a diagnosis of depressive illness. Between the two
identified groups (never experienced depressive illness
and current or history of depressive illness) there was
no statistically significant difference with regard to
sex, age, employment, type of epilepsy or number of
anti-epileptic drugs being prescribed.
Within the questionnaire, patients were asked to
indicate to what extent having epilepsy affected their
lives in certain areas. This was done by use of a Likert
scale and the areas of life assessed were: fatigue, work
opportunity, mobility, social relationships, sexual
relationships and general activity level. This should
have allowed a simple overall assessment of the degree
to which the patient felt handicapped by epilepsy.
Of these areas, the only ones to show a significant
association with depressive illness using the chi
squared test were an effect on mobility and an effect
on general activity (both P < 0.01) (see Table 1).
When this comparison was restricted to those currently
diagnosed with a depressive illness, the difference was
even more marked and a perceived marked effect on
the individual’s sexual and social relationships were
also found to be associated with depressive illness.
Of the 78 patients involved in the study all had
either an EEG, CT scan or MRI with most having
two of these tests. This allowed comparisons to be
made between those patients having an identified
focus and those not. In all 34 (44%) had a focus
identified and this itself was linked with depressive
illness (P < 0.001) as was the focus being present
on the right side (P < 0.001) (see Table 1)—thus
those with a left-sided lesion were less likely to
have a depressive episode than the group as a whole.
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Probably the most robust finding of previous studies
was an association between an anatomical feature of
epilepsy and depressive illness is the presence of a
temporal lobe focus2, 3. However, not only did this
study fail to demonstrate such an association but also
failed to show a trend towards this finding.
Table 1: Statistically significant factors associated with
depressive illness in epilepsy.
No depressive Presence or history of
illness depressive illness
n = 47 n = 31
Right sided lesion 11 (23%) 13 (42%)
Diagnosed when adult 18 (38%) 12 (55%)
Greatly effects mobility 13 (28%) 14 (45%)
Greatly effects activity 14 (30%) 13 (42%)
<1 attack per month 18 (35%) 5 (16%)
Patients who had experienced a depressive episode
were more likely to have been diagnosed with epilepsy
in adulthood (>21 years) than those with no such
history (55% vs. 38% significant for P < 0.001)
and more likely to be having one fit or more per
month (16% vs. 35% significant for P < 0.001) (see
Table 1). There was also, not surprisingly, a trend
for people with depressive illness to be having more
frequent attacks.
As there was a possibility of selective bias in the
sample from those declining to take part in the study,
the above features were compared between the group
being studied and the group declining. Using the chi-
squared test no statistically significant difference was
found.
DISCUSSION
The factors identified that could be seen to indicate
a psychosocial cause were diagnosis in adulthood,
having more than one or more attacks per month and
perceived marked reduction in mobility and general
activity due to having epilepsy. However, though it
is tempting to identify a causal effect which has
some prima facie validity, it must be remembered
that common symptoms of depressive illness itself
are social withdrawal and loss of interest in outside
activities. Thus it may be that patients are simply
describing their symptoms of depression and wrongly
attributing them to epilepsy. It is, however, difficult
to argue that epilepsy does not have a large effect
on lifestyle in these areas. Driving is generally not
permitted unless epilepsy is well controlled and the
uncertainty of when the next attack may occur leads
many people with poorly controlled epilepsy to be
reluctant to leave familiar or safe environments. This
loss of opportunity and difficulty adjusting to it may
be one reason why those who also have a depressive
illness were found to have been more likely to have
been diagnosed in adulthood.
With regard to factors that would support an
association linked with brain structure or activity, the
findings in this study are at odds with the weight of
research thus far. It is generally considered that a left-
sided locus rather than one on the right side, would be
associated with depressive illness. The reasons for this
difference are unclear. However, a few factors need to
be taken into account. Firstly, it has been established
that patients attending secondary care epilepsy centres
have a lower incidence of depressive illness than
those attending more specialist centres10 and so, with
relatively smaller numbers statistical anomalies are
more likely to occur. In a similar vein, there is also the
suggestion that, compared with psychosocial factors,
the effect of an epileptic focus may be small5, again,
with the result of greater likelihood of statistical
artefacts. Finally, it would clearly be unwise to forget
the 40% of clinic attendees who did not take part in
the study. Though there was no significant difference
in presence or laterality of focus when compared with
the responders, little can be said about the presence or
otherwise of a depressive illness. Thus, when looking
for a potentially small effect, this could be crucial.
Given that depressive illness is a relatively common
disorder (prevalence of 5–8% in the general popula-
tion), when looking for factors that lead to develop in
those with epilepsy, it is important to remember that
a significant proportion could have been expected to
develop the illness regardless of features of epilepsy.
Similarly, this study like many others has looked at
epilepsy as a whole. Given that depressive illness has a
complex aetiology it is likely that different factors are
relevant in different cases. For example, the learned
helplessness model7 may be more relevant in people
with more than one type of seizure (as this may result
in less predictability of an attack) and thus be a factor
in explaining the apparent increased incidence of de-
pression in this specific group11. By studying the het-
erogeneous group of people with epilepsy as a whole,
it is possible that factors important for some people in
the aetiology of depressive illness are losing signifi-
cance when a larger, more diverse group is studied.
LIMITATIONS
The multifactorial nature of depressive illness and the
varying relevance of such aetiological factors between
individuals has already been discussed. In order to
identify these with statistical significance requires
large studies with detailed information. Though in
this study there was considerable clinical information
available, 52 people (40%) either declined to take part
in the study or were excluded as the questionnaires
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were not fully completed. This represents a significant
loss of power for the study.
The reluctance of patients from the neurology outpa-
tient clinics to see psychiatrists has been commented
on already12 and clinical screening for depressive
illness by a psychiatrist would be impractical and
unacceptable to most patients. A screening tool must
therefore be used which can not be 100% sensitive and
does not have the flexibility that a clinical assessment
does. For this study, the HAD was used as it was
designed for use in the medically unwell population. It
has been suggested that whilst the HAD is a relatively
sensitive instrument (80–100%) it has a low positive
predictive value9 and so should be used (as in this
case) as a screening instrument rather than one for
diagnosis. This identifies two possible sources of error
in this study: firstly four patients scoring above the
cut-off point of 8 and declining clinical interview by
the psychiatrist were excluded from the study thus a
significant group was lost, and secondly there would
be up to 20% of people with depressive illness not
identified by the rating scale and thus included in the
wrong group for comparison.
CONCLUSIONS
In this study, the only features of people with epilepsy
found to be statistically significantly associated with
the presence of depressive illness were: a right-sided
focus/lesion, diagnosis in adulthood, a perception that
having epilepsy severely affects mobility or general
activity and having one or more attacks each month.
Many of these findings are not in accordance with
previous studies investigating the problem, though
establishing robust anatomical associations between
the two disorders has been difficult and this study,
to some extent adds further to the uncertainty. It
is interesting, however, that both anatomical and
psychosocial variables have shown significant associ-
ations which would support a multifactorial model.
REFERENCES
1. Lewis, A. J. Melancholia: a historical view. J Ment Sci 1934;
80: 1–42.
2. Currie, S., Heathfield, K. W. G., Henson, R. A. and
Scott, D. F. Clinical course and prognosis of temporal lobe
epilepsy. A survey of 666 patients. Brain 1971; 94: 173–190.
3. Mendez, M. F., Cummings, J. L. and Benson, D. F. Depression
in epilepsy. Archives of Neurology 1986; 43: 766–770.
4. Victoroff, J. I., Benson, D. F., Engel, J. Jr, Grafton, S. and
Mazziotta, J. C. Interictal depression in patients with
medically intractable complex partial seizures: electroen-
cephalography and cerebral metabolic correlates. Annals of
Neurology 1990; 28: 221.
5. Robertson, M. M., Trimble, M. R. and Townsend, H. R. A. The
phenomenology of depression in epilepsy. Epilepsia 1987; 28:
364–372.
6. Hermann, B. P. Psychopathology in epilepsy and learned
helplessness. Medical Hypotheses 1979; 5: 723–729.
7. Seligmann, M. E. P. Helplessness: On Depression, Develop-
ment and Death. San Francisco, WHO Freeman, 1975.
8. Zigmond, A. S. and Snaith, R. P. The hospital anxiety and
depression scale. Acta Psychiatrica Scandinavica 1983; 67:
361–370.
9. Silverstone, P. H. Poor efficacy of the hospital anxiety
and depression scale in the diagnosis of major depressive
disorder in both medical and psychiatric patients. Journal of
Psychosomatic Research 1994; 38: 441–450.
10. Robertson, M. M., Channon, S. and Baker, J. Depressive
symptomatology in a general hospital sample of outpatients
with temporal lobe epilepsy: a controlled study. Epilepsia
1994; 35: 771–777.
11. Dodrill, C. B. and Batzell, L. W. Inter-ictal behaviour features
in people with epilepsy. Epilepsia 1986; 27 (Suppl. 2):
S64–S76.
12. Carson, A. J., Ringbauer, B., MacKenzie, L., Warlow, C. and
Sharpe, M. Neurological disease, emotional disorder and
disability: they are related: a study of 300 consecutive new
referrals to a neurology outpatient department. Journal of
Neurology, Neurosurgery and Psychiatry 2000; 68: 202–206.
13. Curran, S. and de Pauw, K. Selecting an antidepressant for use
in a patient with epilepsy. Safety considerations. Drug Safety
1998; 18: 125–133.
